Legislators
Bills
Statements
Lobbying
Travel
Searching...- Bills
- S.1115
S.1115: Making Pharmaceutical Markets More Competitive Act
About This Bill
- This bill was introduced in the 115th Congress
- This bill is primarily about health
- Introduced May 11, 2017
- Latest Major Action May 11, 2017
Bill Sponsor
Bill Cosponsors
3 (2 Democrats, 1 Republican)
Bill Version
- Introduced in Senate - May 11, 2017
Bill Summary
Making Pharmaceutical Markets More Competitive Act This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to prioritize the review of generic drug applications and supplements with respect to drugs that are in a shortage or for which there are not more than three approved drugs. The holder of an approved drug application must notify the FDA within 180 days of withdrawing or transferring the...
(Source: Library of Congress)
What Lawmakers Are Saying About This Bill
Bill Actions
| Date | Description |
|---|---|
| May 11, 2017 |
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
|
| May 11, 2017 |
Introduced in the Senate by Susan Collins (R-Maine) |